3rd Cell & Gene Therapy Research & Development Congress: Asia

 

VIEW AGENDA

Cell and gene therapies are revolutionizing the way we treat diseases, offering new hope for conditions that previously had limited treatment options. The Asia Pacific region is at the forefront of this innovative field, with many countries investing heavily in the research and development of these promising therapies. The rapidly-growing focus is driving a wave of creative solutions in the sector, and as cell and gene therapies continue to advance, the treatment of complex diseases will not only transform but also redefine the pharmaceutical industry as we know it.

The 3rd Cell & Gene Therapy Research & Development Congress: Asia will showcase the latest scientific developments, clinical stage studies and success stories in the field. Sessions include topics on emerging technology, regulatory landscapes and ethical consideration, stem cell and T-cell research, gene editing, among others.

Confirmed speakers

Ivan Horak

Ivan Horak

Founder & CEO, Tikva Allocell, Singapore

Cheng- Yi (Jerry) Kuo

Cheng- Yi (Jerry) Kuo

Vice General Manager, UWELL Biopharma, Taiwan

Deborah Rathjen

Deborah Rathjen

CEO, Carina Biotech, Australia

Jiamin Loo

Jiamin Loo

Senior Director, Discovery, Nuevocor, Singapore

Joe Yeong

Joe Yeong

Immunopathology Director, Singapore General Hospital, Singapore

John Luk

John Luk

CEO and Chairman, Arbele Therapeutics, Hong Kong

Lakshmikanth Gandikota

Lakshmikanth Gandikota

Head of R&D, Immuneel Therapeutics, India

Su Xiao

Su Xiao

Co-founder and Chief Technology Operations Officer, Neurophth Biotechnology, China

Sunil Gadekar

Sunil Gadekar

Director Manufacturing Science and Technology Advanced Therapies, Johnson & Johnson, Singapore

Jackwee Lim

Jackwee Lim

Senior Scientist, Singapore Immunology Network and Co-Founder, HLA-SG, Singapore

Phil Huang

Phil Huang

R&D Director, StemCyte International, Taiwan

default

James Li

CEO and Chairman, JW Therapeutics, China

default

Jane Langford

Senior Director, Cell Therapy, Gilead Sciences, Australia

default

Priya Nagarajan

Cell and Gene Therapy Intelligence Lead, Data Science and Customer Insights, Bayer, Singapore

AGENDA OVERVIEW

Latest Updates

  • Progress case studies
  • Regulatory landscape and ethical considerations
  • Application of emerging technologies
  • Advances in drug delivery systems

Cell Therapy

  • iPSCs, MSCs, and DSCs in disease therapy
  • Cell source and implications
  • Methods of cell expansion and quality maintenance
  • Application of CAR and CAR-T therapies
  • Strategies to overcome T-cell therapy challenges
  • Allogeneic vs. autologous CAR

Gene Therapy

  • Gene editing tools and technologies
  • Gene delivery tools and methods – viral and non-viral
  • Vector design and development
  • Gene therapy for rare diseases

 

VIEW FULL AGENDA

Poster Presentation

This conference definitely provides an ideal platform to showcase your works with a captive audience. Whether looking for funding, job opportunities or simply wanting to share your work with a like-minded and focused group, poster presentations are an excellent way to join the heart of the congress.

Poster abstract submission deadline is 14th March 2025. Contact: haley@global-engage.com for your abstract submission form or for any inquiries or download HERE.

Book Your Places

  • Fee for Academic/Govt/Non-For-Profit (USD)

    You Pay:
    $599.00
    Multibuy Discounts available
    Buy 3 places pay: $399.33
    Buy 5 places pay: $359.40
    X

    How many would you like?

    Add To Basket
  • Fee for Industry (USD)

    You Pay:
    $599.00
    Multibuy Discounts available
    Buy 3 places pay: $399.33
    Buy 5 places pay: $359.40
    X

    How many would you like?

    Add To Basket
  • Solution or Technology Provider (USD)

    You Pay:
    $1,399.00
    No Multibuy Discounts
       
       
       
    X

    How many would you like?

    Add To Basket

20+ speakers

7+ hours of networking

Poster presentation

Exhibition of products & technology

2024 Sponsors

Gold
Silver

For technology or solution provider / vendor / consultant who wish to speak or exhibit and sponsor this event, kindly contact Reuben Raj at reuben@global-engage.com for special packages.

 

Why attend?

1

Returning for its 3rd year due to high demand

2

Attracts over 20+ speakers and 100+ attendees

3

Explores advancements and latest clinical and pre-clinical developments in cell and gene therapies

4

Interesting topics including stem cell regeneration, T-cell and CAR-T applications in immuno-oncology, and novel gene editing tools and delivery methods.

Venue

Singapore (exact venue will be announced soon)

sign up & stay informed


    Meet Your Next Big Client – Sponsor An Event

    Sponsor a Global Engage meeting to access senior professionals in the life science industry and build your brand. Our events offer extensive networking opportunities, workshops, speaking positions, one-to-one delegate meetings, and exhibition booths to showcase your products and services. Gain a competitive advantage and position your company as a thought leader. Call us at UK +44 (0)1865 849841 Malaysia +603 2779 0098 to learn more.

    Our Commitment To Sustainability

    Global Engage is committed to hosting sustainable meetings.

    Event App

    We have reduced waste by replacing printed documentation with an app. Make sure you have it downloaded to your devices in time for the meeting.

    Catering

    You will have some great food choices while you are with us but now, we have worked with the caterer to increase the proportion of plant-based items. We have also built a plan with the venue to avoid waste through how they serve meals and how leftovers are processed.

    Travel

    An international meeting does involve travel but where it is practical, please consider more sustainable alternatives to flying. The app will also have a discussion space to arrange ride shares.

    img